img

Gefitinib Industry: Global Market Opportunities and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 432 | Industry : Pharma & Healthcare

Publisher : MRG | Format : PDF

Gefitinib Industry: Global Market Opportunities and Forecast 2024-2034

This report provides a comprehensive analysis of current global Gefitinib market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Gefitinib industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Gefitinib market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Gefitinib Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Gefitinib market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Gefitinib Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Gefitinib industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
10 Tables/Box
30 Tables/Box

Segmented by Application
Hospital
Clinic
Drug Center
Other

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Sichuan Xieli Pharmaceutical
Qilu Pharmaceutical
Panacea Biotec
Nobel Ilac Sanayii Ve Ticaret
Nishchay Pharmaceuticals
Natco Pharma
Jodas Expoim
Hetero Drugs
Globela Pharma
Glenmark Pharmaceuticals
Flagship Biotech International
Ethypharm
Dr Reddy's Laboratories
Cipla
Celon Laboratories
Cadila Pharmaceuticals
AstraZeneca
Accure Labs


Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Gefitinib Market Status and Forecast (2016-2027)
1.3.2 Global Gefitinib Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Gefitinib Supply by Company
2.1 Global Gefitinib Sales Volume by Company
2.2 Global Gefitinib Sales Value by Company
2.3 Global Gefitinib Price by Company
2.4 Gefitinib Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Gefitinib Market Status by Type
3.1 Gefitinib Type Introduction
3.1.1 10 Tables/Box
3.1.2 30 Tables/Box
3.1.3 90 Tables/Box
3.2 Global Gefitinib Market by Type
3.2.1 Global Gefitinib Sales Volume by Type (2016-2021)
3.2.2 Global Gefitinib Sales Value by Type (2016-2021)
3.2.3 Global Gefitinib Price by Type (2016-2021)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Gefitinib Market Status by Application
4.1 Gefitinib Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Drug Center
4.1.4 Other
4.2 Global Gefitinib Market by Application
4.2.1 Global Gefitinib Sales Volume by Application (2016-2021)
4.2.2 Global Gefitinib Sales Value by Application (2016-2021)
4.2.3 Global Gefitinib Price by Application (2016-2021)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Gefitinib Market Status by Region
5.1 Global Gefitinib Market by Region
5.1.1 Global Gefitinib Sales Volume by Region
5.1.2 Global Gefitinib Sales Value by Region
5.2 North America Gefitinib Market Status
5.3 Europe Gefitinib Market Status
5.4 Asia Pacific Gefitinib Market Status
5.5 Central & South America Gefitinib Market Status
5.6 Middle East & Africa Gefitinib Market Status
6 North America Gefitinib Market Status
6.1 North America Gefitinib Market by Country
6.1.1 North America Gefitinib Sales Volume by Country (2016-2021)
6.1.2 North America Gefitinib Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Gefitinib Market Status
7.1 Europe Gefitinib Market by Country
7.1.1 Europe Gefitinib Sales Volume by Country (2016-2021)
7.1.2 Europe Gefitinib Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Gefitinib Market Status
8.1 Asia Pacific Gefitinib Market by Country
8.1.1 Asia Pacific Gefitinib Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Gefitinib Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Gefitinib Market Status
9.1 Central & South America Gefitinib Market by Country
9.1.1 Central & South America Gefitinib Sales Volume by Country (2016-2021)
9.1.2 Central & South America Gefitinib Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Gefitinib Market Status
10.1 Middle East & Africa Gefitinib Market by Country
10.1.1 Middle East & Africa Gefitinib Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Gefitinib Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Gefitinib Manufacturing Cost Analysis
11.5 Gefitinib Sales Channel and Distributors Analysis
11.5.1 Gefitinib Sales Channel
11.5.2 Gefitinib Distributors
11.6 Gefitinib Downstream Major Buyers
12 Global Gefitinib Market Forecast by Type and by Application
12.1 Global Gefitinib Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Gefitinib Forecast by Type
12.2.1 Global Gefitinib Sales Volume Forecast by Type
12.2.2 Global Gefitinib Sales Value Forecast by Type
12.2.3 Global Gefitinib Price Forecast by Type
12.3 Global Gefitinib Forecast by Application
12.3.1 Global Gefitinib Sales Volume Forecast by Application
12.3.2 Global Gefitinib Sales Value Forecast by Application
12.3.3 Global Gefitinib Price Forecast by Application
13 Global Gefitinib Market Forecast by Region/Country
13.1 Global Gefitinib Market Forecast by Region (2022-2027)
13.1.1 Global Gefitinib Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Gefitinib Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Zuventus Healthcare
14.1.1 Company Information
14.1.2 Gefitinib Product Introduction
14.1.3 Zuventus Healthcare Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 United Biotech
14.2.1 Company Information
14.2.2 Gefitinib Product Introduction
14.2.3 United Biotech Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Sichuan Xieli Pharmaceutical
14.3.1 Company Information
14.3.2 Gefitinib Product Introduction
14.3.3 Sichuan Xieli Pharmaceutical Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Qilu Pharmaceutical
14.4.1 Company Information
14.4.2 Gefitinib Product Introduction
14.4.3 Qilu Pharmaceutical Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Panacea Biotec
14.5.1 Company Information
14.5.2 Gefitinib Product Introduction
14.5.3 Panacea Biotec Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Nobel Ilac Sanayii Ve Ticaret
14.6.1 Company Information
14.6.2 Gefitinib Product Introduction
14.6.3 Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Nishchay Pharmaceuticals
14.7.1 Company Information
14.7.2 Gefitinib Product Introduction
14.7.3 Nishchay Pharmaceuticals Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Natco Pharma
14.8.1 Company Information
14.8.2 Gefitinib Product Introduction
14.8.3 Natco Pharma Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 Jodas Expoim
14.9.1 Company Information
14.9.2 Gefitinib Product Introduction
14.9.3 Jodas Expoim Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 Hetero Drugs
14.10.1 Company Information
14.10.2 Gefitinib Product Introduction
14.10.3 Hetero Drugs Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
14.11 Globela Pharma
14.12 Glenmark Pharmaceuticals
14.13 Flagship Biotech International
14.14 Ethypharm
14.15 Dr Reddy's Laboratories
14.16 Cipla
14.17 Celon Laboratories
14.18 Cadila Pharmaceuticals
14.19 AstraZeneca
14.20 Accure Labs
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Gefitinib Sales Value and CAGR by Region (2016-2027)
Table Global Gefitinib Sales Volume by Company (2019-2021)
Table Global Gefitinib Sales Volume Market Share by Company (2019-2021)
Table Global Gefitinib Sales Value by Company (2019-2021)
Table Global Gefitinib Sales Value and CAGR by Region (2016-2027)
Table Global Gefitinib Price by Company (2019-2021)
Table Main Manufacturers Gefitinib Product Location and Sales Area
Table Global Gefitinib Sales Value by Company (2019-2021)
Table Global Gefitinib Sales Volume by Type (2016-2021)
Table Global Gefitinib Sales Volume Market Share by Type (2016-2021)
Table Global Gefitinib Sales Value by Type (2016-2021)
Table Global Gefitinib Sals Value Market Share by Type (2016-2021)
Table Global Gefitinib Price by Type (2016-2021)
Table North America Gefitinib Sales Volume by Type (2016-2021)
Table Global Gefitinib Sales Value by Type (2016-2021)
Table Europe Gefitinib Sales Volume by Type (2016-2021)
Table Europe Gefitinib Sales Volume Market Share by Type (2016-2021)
Table Asia Pacific Gefitinib Sales Volume by Type (2016-2021)
Table Asia Pacific Gefitinib Sales Volume Market Share by Type (2016-2021)
Table Central & South America Gefitinib Sales Volume by Type (2016-2021)
Table Central & South America Pacific Gefitinib Sales Volume Market Share by Type (2016-2021)
Table Middle East & Africa Gefitinib Sales Volume by Type (2016-2021)
Table Middle East & Africa Gefitinib Sales Volume Market Share by Type (2016-2021)
Table Global Gefitinib Sales Volume by Application (2016-2021)
Table Global Gefitinib Sales Volume Market Share by Application (2016-2021)
Table Global Gefitinib Sales Value by Application (2016-2021)
Table Global Gefitinib Value Market Share by Application (2016-2021)
Table Global Gefitinib Price by Application (2016-2021)
Table North America Gefitinib Sales Volume by Application (2016-2021)
Table Global Gefitinib Sales Value by Application (2016-2021)
Table Europe Gefitinib Sales Volume by Application (2016-2021)
Table Europe Gefitinib Sales Volume Market Share by Application (2016-2021)
Table Asia Pacific Gefitinib Sales Volume by Application (2016-2021)
Table Asia Pacific Gefitinib Sales Volume Market Share by Application (2016-2021)
Table Central & South America Gefitinib Sales Volume by Application (2016-2021)
Table Central & South America Pacific Gefitinib Sales Volume Market Share by Application (2016-2021)
Table Middle East & Africa Gefitinib Sales Volume by Application (2016-2021)
Table Middle East & Africa Gefitinib Sales Volume Market Share by Application (2016-2021)
Table Global Gefitinib Sales Volume by Region (2016-2021)
Table Global Gefitinib Sales Volume Market Share by Region (2016-2021)
Table Global Gefitinib Sales Value by Region (2016-2021)
Table Global Gefitinib Value Market Share by Region (2016-2021)
Table North America Gefitinib Sales Volume by Country (2016-2021)
Table North America Gefitinib Sales Volume Market Share by Country (2016-2021)
Table Global Gefitinib Sales Value by Region/Country (2016-2021)
Table North America Gefitinib Value Market Share by Country (2016-2021)
Table Europe Gefitinib Sales Volume by Country (2016-2021)
Table Europe Gefitinib Sales Volume Market Share by Country (2016-2021)
Table Europe Gefitinib Sales Value by Country (2016-2021)
Table Europe Gefitinib Value Market Share by Country (2016-2021)
Table Asia Pacific Gefitinib Sales Volume by Country (2016-2021)
Table Asia Pacific Gefitinib Sales Volume Market Share by Country (2016-2021)
Table Asia Pacific Gefitinib Sales Value by Country (2016-2021)
Table Asia Pacific Gefitinib Value Market Share by Country (2016-2021)
Table Central & South America Gefitinib Sales Volume by Country (2016-2021)
Table Central & South America Gefitinib Sales Volume Market Share by Country (2016-2021)
Table Central & South America Gefitinib Sales Value by Country (2016-2021)
Table Central & South America Gefitinib Value Market Share by Country (2016-2021)
Table Middle East & Africa Gefitinib Sales Volume by Country (2016-2021)
Table Middle East & Africa Gefitinib Sales Volume Market Share by Country (2016-2021)
Table Middle East & Africa Gefitinib Sales Value by Country (2016-2021)
Table Middle East & Africa Gefitinib Value Market Share by Country (2016-2021)
Table Gefitinib Raw Materials Key Suppliers List
Table Gefitinib Distributors List
Table Gefitinib Buyers List
Table Global Gefitinib Sales Volume Forecast by Type (2022-2027)
Table Global Gefitinib Sales Volume Market Share Forecast by Type (2022-2027)
Table Global Gefitinib Value Forecast by Type (2022-2027)
Table Global Gefitinib Value Market Share Forecast by Type (2022-2027)
Table Global Gefitinib Price Forecast by Type (2022-2027)
Table Global Gefitinib Sales Volume Forecast by Application (2022-2027)
Table Global Gefitinib Value Forecast by Type (2022-2027)
Table Global Gefitinib Value Forecast by Application (2022-2027)
Table Global Gefitinib Value Market Share Forecast by Application (2022-2027)
Table Global Gefitinib Price Forecast by Application (2022-2027)
Table Global Gefitinib Sales Volume Forecast by Region (2022-2027)
Table Global Gefitinib Value Forecast by Application (2022-2027)
Table Global Gefitinib Value Forecast by Region (2022-2027)
Table Global Gefitinib Value Market Share Forecast by Region (2022-2027)
Table Zuventus Healthcare Company Information
Table Zuventus Healthcare Product Introduction
Table Global Gefitinib Value Forecast by Region (2022-2027)
Table United Biotech Company Information
Table United Biotech Product Introduction
Table United Biotech Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Sichuan Xieli Pharmaceutical Company Information
Table Sichuan Xieli Pharmaceutical Product Introduction
Table Sichuan Xieli Pharmaceutical Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Qilu Pharmaceutical Company Information
Table Qilu Pharmaceutical Product Introduction
Table Qilu Pharmaceutical Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Panacea Biotec Company Information
Table Panacea Biotec Product Introduction
Table Panacea Biotec Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Nobel Ilac Sanayii Ve Ticaret Company Information
Table Nobel Ilac Sanayii Ve Ticaret Product Introduction
Table Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Nishchay Pharmaceuticals Company Information
Table Nishchay Pharmaceuticals Product Introduction
Table Nishchay Pharmaceuticals Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Natco Pharma Company Information
Table Natco Pharma Product Introduction
Table Natco Pharma Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Jodas Expoim Company Information
Table Jodas Expoim Product Introduction
Table Jodas Expoim Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Hetero Drugs Company Information
Table Hetero Drugs Product Introduction
Table Hetero Drugs Gefitinib Sales Volume, Price, Sales Value and Gross Margin (2019-2021)